Global Lung Oncology Branch trial 3 (GLOB 3): Quality of Life (QoL) results of a randomised multinational Phase III trial of oral and i.v. vinorelbine (NVB) plus cisplatin (CDDP) versus docetaxel (DTX) plus CDDP as first-line treatment for advanced non-small cell lung cancer (NSCLC)

被引：1
|
作者：
Rolski, J. [1 ]
Grodzki, T. [2 ]
Schneider, C. P. [3 ]
Zatloukal, P. [4 ]
Reck, M. [5 ]
Aitin, E. [6 ]
Tan, E. H.
机构：
[1] Maria Sklodowska Curie Mem Inst Oncol, Krakow, Poland
[2] Reg Hosp Lung Dis, Szczecin, Poland
[3] Cent Clin Bad Berka, Bad Berka, Germany
[4] Pneumol Clin, Prague, Czech Republic
[5] Krankenhaus Grosshansdorf, Grosshansdorf, Germany
[6] Hosp Carlo Poma, Mantova, Italy
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71329-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6501
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
  • [41] PHASE II TRIAL OF METRONOMIC ORAL VINORELBINE AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (MOVE TRIAL)
    Camerini, A.
    Puccetti, C.
    Donati, S.
    Valsuani, C.
    Petrella, M. C.
    Tartarelli, G.
    Puccinelli, P.
    Amoroso, D.
    ANNALS OF ONCOLOGY, 2014, 25
  • [42] Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial
    Georgoulias, Vassilis
    Androulakis, Nikolaos
    Kotsakis, Athanasios
    Hatzidaki, Dora
    Syrigos, Kostas
    Polyzos, Aris
    Agelidou, Athina
    Varthalitis, Loannis
    Ziras, Nikoalos
    Agelidou, Maria
    Chandrinos, Vassilis
    Boukovinas, Loannis
    Geroyianni, Alexandra
    Vamakas, Larnbros
    Mavroudis, Dirnitris
    LUNG CANCER, 2008, 59 (01) : 57 - 63
  • [43] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: Preliminary results of a phase II trial (move trial)
    Camerini, A.
    Donati, S.
    Valsuani, C.
    Puccetti, C.
    Petrella, M. C.
    Tartarelli, G.
    Puccinelli, P.
    Amoroso, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S825 - S825
  • [44] Sequential versus concomitant administration of docetaxel and gemcitabine as first-line treatment of advanced non-small cell lung cancer (NSCLC):: results of a phase II/III randomised study
    Manegold, C.
    Thatcher, N.
    Kortsik, C.
    Koschel, G.
    Spengler, W.
    Mezgar, J.
    Schott von Romer, K.
    Pilz, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 326 - 326
  • [45] ORAL VINORELBINE (NVBO) plus CISPLATIN (CDDP) AS CHEMORADIOTHERAPY (CT-RT) TREATMENT (TRT) AFTER INDUCTION IN LOCALLY ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): RESULTS OF A PHASE II STUDY
    Lerouge, D.
    Zalcman, G.
    Riviere, A.
    Dansin, E.
    Gervais, R.
    Dujon, C.
    Chouaid, C.
    Lavole, A.
    Precheur-Agulhon, B.
    Biville-Hedouin, F.
    Lartigau, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 135 - 135
  • [46] Phase I/II trial of a low-emetic combination of S-1 plus docetaxel (DTX) for advanced non-small cell lung cancer (NSCLC)
    Komiyama, K.
    Kobayashi, K.
    Minezaki, S.
    Uchida, Y.
    Kasai, T.
    Mori, K.
    Hoshi, E.
    Koyama, S.
    Eguchi, K.
    Nakayama, M.
    Kikuchi, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] Toxicity analysis of SWOG 9509: A randomized phase III trial of paclitaxel plus carboplatin (PC) versus vinorelbine plus cisplatin (VC) in untreated patients with advanced non-small cell lung cancer (NSCLC). A Southwest Oncology Group Trial
    Kelly, K
    Crowley, J
    Bunn, PA
    Livingston, RB
    Gandara, DR
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 24 - 24
  • [48] Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial
    Grigorescu, AC
    Draghici, IN
    Nitipir, C
    Gutulescu, N
    Corlan, E
    LUNG CANCER, 2002, 37 (01) : 9 - 14
  • [49] Phase I/II trial of docetaxel (D) and Carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Giannakakis, T
    Papadouris, S
    Kourousis, C
    Kalbakis, NK
    Tzianni, V
    Lidaki, E
    Androulakis, N
    Souklakos, J
    Sarra, E
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 94
  • [50] Results of a phase I/II trial of carboplatin/gemcitabine plus celecoxib for first-line treatment of stage IIIB/IV non-small cell lung cancer (NSCLC).
    Burton, JD
    El-Sayah, D
    Cherry, M
    Bhargava, M
    Terjanian, T
    Odaimi, M
    Vesoniaraki, M
    Lowry, J
    Forte, F
    Friscia, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
12345